As dressings for moist wound healing, hyaluronic acid hydrogels play a significant role in maintaining moisture and promoting wound healing. However, existing hydrogel dressings are inadequate in terms of slow gelation time, weak mechanical performance, and fast degradation, which increases the risk of secondary infections during treatment. Therefore, we developed a hyaluronic acid double network hydrogel (DNH). Compared to single-network hydrogels (hydrazone and Diels–Alder), DNH shows a short gelation time (25 s) and strong mechanical properties (Young’s modulus = 82 kPa). These advantages enable DNH to immediately fill the irregular shape of the wound after gelation and remain intact after being squeezed. Swelling tests indicated that DNH had a suitable swelling ratio and maintained its structural integrity after swelling. We evaluated the use of DNH as a moist dressing for full-thickness wound healing in vivo. DNH-treated wounds healed faster, with enhanced blood vessel formation and macrophage polarization than gauze-treated wounds. These findings suggest that DNH not only accelerates wound healing but also improves tissue regeneration. Therefore, DNH may be a suitable moist dressing for wound healing.
External environmental stressors and internal physiological changes frequently compromise the skin barrier, resulting in conditions such as dermatitis and dehydration. A key underlying factor is the depletion of ceramides, essential lipids in the stratum corneum that maintain skin integrity. Although topical ceramide supplementation is effective for barrier repair, its clinical application is limited by poor solubility and low skin permeability. To overcome these challenges, this study developed an oil-in-water nanoemulsion (O/W-NE) using ultrasonic emulsification for the efficient transdermal delivery of ceramide C2. Octyldodecanol was selected as the oil phase to enhance ceramide solubility, while glycerin was incorporated to increase aqueous phase viscosity, reduce particle size, and function as a biocompatible penetration enhancer. The optimized nanoemulsion achieved a particle size of 112.5 nm and an encapsulation efficiency of 85%. Its performance was evaluated via in vitro release, ex vivo skin permeation, and in vivo biocompatibility studies. Mechanistic investigations revealed that both particle size and glycerin concentration significantly influenced ceramide penetration into the epidermis and dermis. Additionally, the nanoemulsion exhibited moisturizing and barrier-repair effects in a damaged skin model. Overall, this O/W-NE offers a stable, non-invasive strategy for enhancing ceramide delivery and restoring skin barrier function.
26 November 2024 in Journal of Bioscience and Bioengineering